This content is from: Premium
Perceptive Advisors Turns Big Loss into Hefty Gain
Joseph Edelman’s biotech fund, whose performance landed him on the Rich List last year, was down by double digits this year but has since bounced back and then some.
Joseph Edelman, Perceptive Advisors (Bloomberg) Now, this is what you call a comeback. The Perceptive Life Sciences Fund, managed by Joseph Edelman’s New York–based Perceptive Advisors, suffered a 12 percent loss in January and was down 17 percent through February, its low point. But it is now solidly back in the black. The
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.